Evidence map›Paper›PMID 41820682›Full record

ReviewAdvances in biochemical engineering/biotechnology2026

Mathematical Modeling.

Botond Szilágyi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in biochemical engineering/biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Botond SzilágyiBudapest University of Technology and Economics, Budapest, Hungary. szilagyi.botond@vbk.bme.hu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Solution crystallization is becoming increasingly important as separation, purification, and controlled particle formation of biomolecules in pharmaceutical applications, with high potential as a green and scalable method at an industrial level. As this book's previous chapters discussed already, a large amount of attention is paid to the fundamental aspects of nucleation and growth, as triggering the crystallization of macromolecules is often challenging. Once the suitable ranges of the key thermodynamic conditions are identified, such as the solvent system, precipitating agent, concentration, pH, and temperature, the toolsets of the crystallization process engineering, relying on mathematical modeling, can support the process understanding, design, optimization, and control/operation.As a primer to this chapter, one must keep in mind that the results drawn from the relatively small number of proteins and other biomolecular systems studied in detail in the past indicate that a strong correspondence exists between the growth behavior and mechanisms of the biomolecule crystals with theories accumulated into the crystallization of inorganic small-molecule crystals. Although there is no guarantee that all protein and other biomolecular systems analyzed in the future will obey the same or similar fundamental rules, given the available evidence, a generic crystallization modeling and control overview will be given here. This chapter is divided into two main sections. Firstly, the mathematical modeling and simulation aspects will be described, which can help to understand, analyze, and optimize the processes on a manufacturing level. Secondly, control solutions will be presented for crystallizers that enable the realization of the desired products.

Indexed as

Models, ChemicalProteinsComputer SimulationCrystallizationThermodynamicsProteinsBiomolecular crystallizationCrystallization process designMetastable intermediate phaseNucleation and growth kineticsParticle size distributionPopulation balance modelingProcess analytical technologySolubity modeling

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.